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ever, whether CRT is involved in the pathogenesis of diabetic car-
diomyopathy (DCM) is still unknown. Our aim was to explore the
expression of CRT in the myocardium of streptozotocin-induced DCM.
METHODS 40 female SD rats were randomly divided into control
group and DCM group (accepted a single injection of streptozotocin
(65mg/Kg)). The change of cardiac structure was observed by ul-
trasonic cardiogram. At the end of 10 weeks and 16 weeks after
injection, control rats and DCM rats were sacriﬁced. The level of the
CRT in myocardium was explored by reverse transcription-poly-
merase chain reaction (RT-PCR) and immunohistochemistry. Then
changes in heart ultrastructure were also analyzed by using hemo-
toxylin and eosin staining and transmission electron microscopy. All
data were analyzed by the independent samples t test in SPSS 17.0
software.
RESULTS Ultrasonic cardiogram did not reveal that there were sig-
niﬁcant differences between control group and DCM group at the 8
weeks and 12 weeks. However, the LVEDV and LVESV signiﬁcantly
increased (P < 0.05), meanwhile LVEF decreased (P < 0.05) in DCM
group at the end of 16 weeks. 10 weeks after accepted streptozotocin,
electron microscopy showed that there were myoﬁbrillar disarrange-
ments and fracture, nuclear edema, mitochondrial proliferation, swell
and membrane loss, and endoplasmic reticulum dilation in the
myocardium of DCM rats. Then these changes were more serious at
the end of 16 weeks. Compared with control group, a signiﬁcant in-
crease of CRT expression was also observed in cardiac muscle of DCM
at the end of 16 weeks (P < 0.05).
CONCLUSIONS Our study provides experimental evidence that there
was myocardium subcellular remodeling observed by electron
microscopic and the expression of CRT was up-regulated in the
development of DCM which might contribute to the cardiac dys-
function.
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OBJECTIVES To investigate the effects of all-trans retinoic acid
(ATRA) on the luminal stenosis, the phenotypic and proliferation
modulation of vascular smooth muscle cell(VSMCs). The impacts of
ATRA on expression changes of cyclin dependent kinase inhibitor
P21cip1, P27kip1 in rats artery after aortic balloon withdrawal injury.
To disclose the mechanisms by which ATRA prevent restenosis after
percutaneous coronary intervention(PCI).
METHODS 54 SD rats were randomly divided into 3 groups. All rats
were dosed with ATRA(30mg.kg-1.d-1) or corn oil by gavage 4 days
before operation and continued to indicated times. Group 1(n¼6)
served as controls and were raised 28 days after sham-operation.
Group 2 (operation group n¼24) and Group 3 (ATRA group n¼24)
had aortic balloon withdrawal injury and were killed at 2,7,14,28
days after endothelium denudation. After the thoracic aorta were
obtained, vessel morphological measurement was taken, and
immunohistochemistry (IHC) staining were used to measure the
protein expression of SM-a-actin, PCNA, cyclin dependent kinase
inhibitor P21and P27.
RESULTS In operation group, there were signiﬁcant neointima for-
mation and luminal stenosis at day 14 and day 28(28d: 1.6410.088
vs 2.0430.108, P<0.01). Histomorphometry revealed ATRA-medi-
ated decrease in neointima area (28d: 0.0750.017 vs 0.1730.030,
P<0.01) as well as signiﬁcant increase in luminal area (1.9010.085
vs 1.6410.088, P<0.01), larger internal and external elastic lamina
area (P<0.01) at day 28. After balloon injury, the expression of SM-a-
actin was downregulated signiﬁcantly and reached the lowest at day
2; in tunica intima, SM-a-actin could be measured notable at day 14
and 28; the expression of PCNA increased obviously and reached the
peak at day 2; in tunica intima, VSMC proliferated extremely at day 7
and then decreased. In normal rat arteries P21 was not detected;
after balloon injury, P21 can be detected at day 14 and 28. After
endothelium denudation by balloon, P27 expression in media
decreased, reached the lowest level at day 2 and then upregulated;
in neointima, P27 could be detected at day 14 and 28. In ATRA
-treated group SM-a-actin was upregulated in both media and neo-
intima, P21 was already present in the neointima at day 7 and
strongly expressed at day 14 and 28, and P27 downregulation was
inhibited in media and was already present in the neointima at day 7
and strongly expressed at day 14 and 28, while the proliferation ofVSMC was decreased signiﬁcantly (P<0.01). The expression of SM-a-
actin, P21, P27 and the cell proliferation (PCNA) were in remarkable
negative correlation(P<0.01).
CONCLUSIONS There were distinct neointima formation and luminal
stenosis after aortic balloon withdrawal injury. Inhibiting the progress
of cell proliferation cycle by maintaining and inducing the expression
of SM-a-actin, P21, P27 may be one mechanism by which ATRA
reduced neointima formation and promoted favorable geometric
remodeling after Vascular injury.
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OBJECTIVES To observe the effect of QiShenYiQi pill (QSYQ) on aortic
remodeling in pressure overload rats induced by partial abdominal
aortic coarctation, and to explore its mechanism of action.
METHODS Wistar rats underwent surgery to produce partial
abdominal aortic coarctation, then 4 weeks later they were ran-
domized into three groups: model, valsartan, and QSYQ groups.
Sham-operated group was as control. After 8 weeks’ successive
administration, Wistar rats were euthanized. We used hematoxylin-
eosin (HE) staining and Masson’s trichrome staining to detect the
pathological morphological changes of aorta, ELISA to detect the
serum endothelin-1 (ET-1) and calcitonin gene-related peptide
(CGRP), and alkaline hydrolysis to detect the content of myocardial
hydroxyproline (HYP). Aortal platelet derived growth factor-A
(PDGF-A) and transformation growth factor-b1 (TGF-b1) mRNA
expression was detected by real-time PCR. PDGF-A and osteopontin
(OPN) protein expression of aorta media and TGF-b1 and a-smooth
muscle-actin (SM a-actin) protein expression of aorta adventitia were
detected by immunohistochemistry.
RESULTS In model group, the aorta thickness increased, vascular
smooth muscle cell (VSMC) in aorta media arranged irregularly, and
the cell nuclear density of VSMC and ﬁbroblast (AF) increased; in
valsartan and QSYQ groups, the aorta thickness decreased, VSMC ar-
ranged regularly in aorta media, and the cell nuclear density of VSMC
and AF decreased. In model group, elastic ﬁber straightened and
fractured, the VSMC hypertrophy was obvious, and the collagen area
percentage of aorta media increased (P<0.01); in valsartan group, the
elastic ﬁber arranged regularly, and the collagen area percentage of
aorta media decreased (P<0.01); QSYQ group showed a similar result;
there was no statistical difference between valsartan and QSYQ
(P>0.05). In model group, serum ET-1 increased (P<0.01) and serum
CGRP decreased (P<0.01); valsartan decreased the serum ET-1
(P<0.01) and increased the serum CGRP (P<0.01); a similar result was
seen in QSYQ group; there was no statistical difference between val-
sartan and QSYQ (P>0.05). In model group, the content of aortic HYP
increased (P<0.01); the content of aortic HYP reduced in both val-
sartan group (P<0.05) and QSYQ group (P<0.01). In model group,
aortic expression of PDGF-A mRNA and TGF-b1 mRNA increased
(P<0.01); in valsartan group, the expression of PDGF-A mRNA and
TGF-b1 mRNA decreased (P<0.01); QSYQ produced a similar effect;
there was no statistical difference between valsartan and QSYQ
groups (P>0.05). Immunohistochemical staining showed the positive
area percentage of PDGF-A and OPN in aorta media increased in model
group (P<0.01); the PDGF-A and OPN expression decreased in both
valsartan and QSYQ groups (P<0.01); there was no statistical differ-
ence between valsartan and QYSQ groups (P>0.05). It also showed the
expression of TGF-b1 and SM a-actin in aorta adventitia increased in
model group (P<0.01); valsartan decreased the positive area per-
centage of TGF-b1 and SM a-actin in aorta adventitia (P<0.01); QSYQ
had a similar effect, and the decrease of TGF-b1 positive area per-
centage was signiﬁcantly greater than that of the valsartan group
(P<0.05).
CONCLUSIONS It provides evidence that QSYQ can improve the
vasomotor dysfunction of aorta, which is related to the mechanism of
regulation the balance of ET-1 and CGRP; it also can inhibit structural
remodeling of aorta, which is related to the mechanism of regulation
the phenotype switch of VSMC in aorta media and AF in aorta ad-
ventitia.
